Knowledge Center

Article / Feb 01, 2015

The Time Has Come

Authors:
  • Goncalo Andrade
  • Peter Villax
  • Carla Vozone
Source:
PMPS, 2015, February, pp. 30 - 33

The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.

With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.

Related links

Read article here

Also in the Knowledge Center

Related Content

Hovione’s contributions to the Sustainable Development Goals

Hovione has aligned its Sustainability Policy and Strategy to the United Nations Sustainable Development Goals

Page
Read more

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more

Virtual Tours

Our doors are open. Welcome to our facilities. We are a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more